Capstar (NYSE:CPSR) announced in an 8-K filing this morning that all but $3.4 million has been removed from its trust via redemptions ahead of its vote to complete its transaction with biotech firm Gelesis.
A total of 27,260,179 shares were redeemed and this included shares held by PIPE investors. Capstar noted that GCCU VI LLC and TOCU XXIX LLC redeemed 1,000,000 shares each, although each have also agreed to purchase 1,750,000 shares via the transaction’s PIPE. But, Capstar already secured the deal’s completion in regards to its minimum cash condition by adding a backstop in late December.
In the end, $11,599,270 will be pulled into the transaction out of the backstop that was designed to provide up to $15 million. As envisaged by the agreement, backstop investors are to receive a larger proportion of shares at close — 1,983,750 — than they purchased through the backstop.
Capstar shareholders are set to vote to complete the deal tomorrow, January 11. The SPAC slid about 2% on its January 7 redemption deadline, but it is receiving upwards interest in the premarket potentially in hopes that it will present a low float opportunity.
The parties initially announced their deal on July 19. Boston-based Gelesis is advancing a series of therapies for weight management and chronic gut conditions with pills designed to fill the stomach ahead of meals that mimic food to but do not add calories.
Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...
At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...